ALMOTRIPTAN MALATE

ALMOTRIPTAN MALATE was reported 547 times

ALMOTRIPTAN MALATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHATIC MALFORMATION 4 0.1053
1 HETEROPHORIA 12 0.0828
2 ALLERGY TO IMMUNOGLOBULIN THERAPY 6 0.0550
3 PLACENTAL CALCIFICATION 1 0.0500
4 VASCULAR GRAFT OCCLUSION 15 0.0391
5 NEUROFIBROSARCOMA 4 0.0388
6 MIGRAINE WITHOUT AURA 11 0.0367
7 CERVICOGENIC HEADACHE 4 0.0294
8 ANISOCORIA 11 0.0291
9 LOCOMOTIVE SYNDROME 1 0.0270
10 PRODUCT USED FOR UNKNOWN INDICATION 33 0.0262
11 RENAL ARTERY DISSECTION 1 0.0250
12 PHONOPHOBIA 11 0.0239
13 MAY-THURNER SYNDROME 4 0.0223
14 LARYNGOTRACHEAL OEDEMA 1 0.0222
15 RETROGRADE AMNESIA 11 0.0217
16 HYPOAESTHESIA EYE 12 0.0203
17 DYSCALCULIA 5 0.0202
18 OCCIPITAL NEURALGIA 11 0.0195
19 FIBROADENOMA OF BREAST 8 0.0178
20 CONGENITAL GASTRIC ANOMALY 1 0.0172
21 SEDATION 354 0.0135
22 SYNOVIAL DISORDER 5 0.0110
23 INTRACRANIAL TUMOUR HAEMORRHAGE 4 0.0103
24 NIGHTMARE 354 0.0102
25 JOINT ANKYLOSIS 5 0.0088
26 CLUSTER HEADACHE 11 0.0080
27 TOXIC INDUCED ENCEPHALOPATHY 1 0.0080
28 ANTACID THERAPY 1 0.0077
29 NEPHROLITHIASIS 319 0.0069
30 MENOMETRORRHAGIA 11 0.0058
31 EXOPHTHALMOS 12 0.0056
32 INTESTINAL ADENOCARCINOMA 1 0.0053
33 DACTYLITIS 5 0.0051
34 SLEEP DISORDER THERAPY 1 0.0051
35 OLIGOARTHRITIS 1 0.0050
36 DESMOID TUMOUR 1 0.0048
37 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
38 COLOUR BLINDNESS 4 0.0044
39 BLOOD IMMUNOGLOBULIN G INCREASED 5 0.0041
40 MIGRAINE WITH AURA 11 0.0040
41 CLUMSINESS 11 0.0040
42 EYE INJURY 11 0.0036
43 ANTICOAGULANT THERAPY 1 0.0035
44 MENOPAUSAL SYMPTOMS 8 0.0034
45 INFUSION SITE DISCHARGE 6 0.0034
46 VULVOVAGINITIS 1 0.0034
47 MYOPIA 8 0.0034
48 VESTIBULAR DISORDER 4 0.0033
49 BACTERIAL VAGINOSIS 5 0.0032
50 BED REST 1 0.0032
51 EXPOSURE TO ALLERGEN 1 0.0031
52 ANALGESIC THERAPY 1 0.0031
53 DRUG THERAPY 1 0.0029
54 COMMUNICATION DISORDER 11 0.0029
55 HYPERHIDROSIS 369 0.0029
56 PRERENAL FAILURE 4 0.0028
57 HYDROCEPHALUS 15 0.0028
58 HYPERTRICHOSIS 5 0.0027
59 SACROILIITIS 5 0.0026
60 APPENDICOLITH 1 0.0026
61 RADIUS FRACTURE 6 0.0025
62 NIGHT BLINDNESS 4 0.0025
63 VULVOVAGINAL DRYNESS 8 0.0025
64 VITAMIN D ABNORMAL 1 0.0024
65 MEDICATION OVERUSE HEADACHE 2 0.0023
66 CONGENITAL FOOT MALFORMATION 1 0.0022
67 ANEURYSM RUPTURED 2 0.0022
68 JUVENILE IDIOPATHIC ARTHRITIS 5 0.0020
69 DUST ALLERGY 2 0.0020
70 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
71 ASTHENOPIA 11 0.0020
72 INTERMENSTRUAL BLEEDING 11 0.0020
73 BURNS THIRD DEGREE 2 0.0019
74 LIGAMENT SPRAIN 18 0.0018
75 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
76 VULVOVAGINAL INJURY 1 0.0018
77 BLEPHAROSPASM 11 0.0017
78 FAT NECROSIS 1 0.0016
79 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
80 EYE MOVEMENT DISORDER 11 0.0016
81 JOINT WARMTH 2 0.0016
82 INFUSION SITE HAEMORRHAGE 5 0.0015
83 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
84 WOUND INFECTION 16 0.0015
85 NASAL DISCHARGE DISCOLOURATION 2 0.0014
86 CLEAR CELL RENAL CELL CARCINOMA 1 0.0014
87 BRONCHIAL OBSTRUCTION 2 0.0014
88 BRAIN CONTUSION 1 0.0014
89 HYPERACUSIS 5 0.0013
90 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
91 RETINAL PIGMENTATION 1 0.0013
92 LIMB MALFORMATION 1 0.0013
93 NASAL ULCER 2 0.0013
94 COSTOCHONDRITIS 2 0.0012
95 EYELID PTOSIS 12 0.0012
96 NODAL ARRHYTHMIA 1 0.0012
97 TENDERNESS 12 0.0012
98 PARONYCHIA 5 0.0011
99 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
100 MENINGITIS ASEPTIC 5 0.0011
101 PRODUCT USE IN UNAPPROVED INDICATION 275 0.0011
102 NASAL OEDEMA 2 0.0011
103 VISUAL FIELD DEFECT 8 0.0011
104 VASOSPASM 1 0.0011
105 RETINOPATHY 4 0.0011
106 BUNDLE BRANCH BLOCK 1 0.0011
107 PLACENTAL DISORDER 1 0.0011
108 ARNOLD-CHIARI MALFORMATION 1 0.0010
109 ANIMAL SCRATCH 1 0.0010
110 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
111 MENINGIOMA 16 0.0010
112 OROPHARYNGEAL SWELLING 1 0.0010
113 HAIR GROWTH ABNORMAL 7 0.0010
114 POLYHYDRAMNIOS 1 0.0010
115 PHOTOPHOBIA 18 0.0010
116 HYPOPERFUSION 1 0.0010
117 PHOTOPSIA 6 0.0009
118 MYDRIASIS 12 0.0009
119 PRODUCT LEAKAGE 5 0.0009
120 HEAVY MENSTRUAL BLEEDING 8 0.0009
121 METABOLIC SURGERY 1 0.0009
122 PUPILS UNEQUAL 1 0.0009
123 SERONEGATIVE ARTHRITIS 1 0.0009
124 COORDINATION ABNORMAL 12 0.0009
125 OVARIAN CYST 8 0.0008
126 NASAL DRYNESS 5 0.0008
127 LUPUS VULGARIS 1 0.0008
128 ABORTION MISSED 1 0.0008
129 RETINAL DEGENERATION 1 0.0008
130 IMPAIRED QUALITY OF LIFE 11 0.0008
131 APATHY 11 0.0008
132 INCISIONAL HERNIA 1 0.0007
133 DISABILITY 14 0.0007
134 TENSION HEADACHE 3 0.0007
135 RENAL INFARCT 1 0.0007
136 AMENORRHOEA 12 0.0007
137 JOINT RANGE OF MOTION DECREASED 9 0.0007
138 PELVIC INFLAMMATORY DISEASE 1 0.0007
139 IMPAIRED WORK ABILITY 14 0.0007
140 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
141 APHTHOUS ULCER 5 0.0006
142 TOTAL LUNG CAPACITY DECREASED 1 0.0006
143 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
144 HYPERAESTHESIA 5 0.0006
145 DEAFNESS NEUROSENSORY 2 0.0006
146 UPPER LIMB FRACTURE 12 0.0006
147 HYPOCALCAEMIA 11 0.0006
148 RETINITIS 1 0.0006
149 FACIAL PAIN 5 0.0006
150 OESOPHAGEAL SPASM 1 0.0005
151 PHARYNGEAL SWELLING 5 0.0005
152 POOR QUALITY SLEEP 11 0.0005
153 JOINT NOISE 1 0.0005
154 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1 0.0005
155 NECK PAIN 28 0.0005
156 NIGHT SWEATS 16 0.0005
157 MUSCLE CONTRACTURE 1 0.0005
158 PRE-EXISTING CONDITION IMPROVED 3 0.0005
159 SPINA BIFIDA 1 0.0005
160 MUSCLE TWITCHING 11 0.0005
161 RENAL PAIN 5 0.0005
162 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
163 HYPERPHOSPHATAEMIA 1 0.0005
164 DIPLOPIA 12 0.0005
165 NAUSEA 354 0.0004
166 SPINAL PAIN 5 0.0004
167 EPILEPSY 13 0.0004
168 VOLVULUS 1 0.0004
169 DIABETES INSIPIDUS 1 0.0004
170 INFREQUENT BOWEL MOVEMENTS 1 0.0004
171 VENTRICULAR HYPERTROPHY 1 0.0004
172 EYELID IRRITATION 1 0.0004
173 MUSCLE ATROPHY 5 0.0004
174 VENTRICULAR DYSFUNCTION 1 0.0004
175 LUNG OPACITY 1 0.0004
176 ANGIONEUROTIC OEDEMA 1 0.0004
177 ALCOHOL POISONING 1 0.0004
178 APPLICATION SITE HAEMORRHAGE 1 0.0004
179 RHINALGIA 1 0.0004
180 LIMB DISCOMFORT 11 0.0004
181 NERVOUS SYSTEM DISORDER 11 0.0004
182 LIP PAIN 1 0.0003
183 COGNITIVE DISORDER 16 0.0003
184 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
185 KERATITIS 1 0.0003
186 OFF LABEL USE 288 0.0003
187 DYSAESTHESIA 1 0.0003
188 PRODUCT DISTRIBUTION ISSUE 3 0.0003
189 SCOLIOSIS 2 0.0003
190 BRAIN FOG 5 0.0003
191 INFUSION SITE PRURITUS 1 0.0003
192 EYE INFLAMMATION 3 0.0003
193 MIGRAINE 30 0.0003
194 SWOLLEN JOINT COUNT INCREASED 1 0.0003
195 LOOSE TOOTH 1 0.0003
196 PHOTOSENSITIVITY REACTION 5 0.0003
197 CRYING 11 0.0003
198 LYME DISEASE 1 0.0003
199 OLIGOHYDRAMNIOS 1 0.0003
200 UVEITIS 4 0.0003
201 PUSTULAR PSORIASIS 1 0.0003
202 MUSCULOSKELETAL DISCOMFORT 5 0.0003
203 AORTIC STENOSIS 1 0.0003
204 MOVEMENT DISORDER 9 0.0003
205 RASH PUSTULAR 2 0.0003
206 ASTHMATIC CRISIS 1 0.0003
207 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
208 URINARY INCONTINENCE 8 0.0003
209 BLINDNESS 11 0.0003
210 MIDDLE INSOMNIA 5 0.0003
211 DRUG INEFFECTIVE 349 0.0003
212 VERTIGO 16 0.0003
213 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
214 POLYDIPSIA 1 0.0003
215 CEREBRAL ATROPHY 1 0.0003
216 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
217 MUSCULOSKELETAL STIFFNESS 21 0.0002
218 IRRITABLE BOWEL SYNDROME 5 0.0002
219 AMNESIA 15 0.0002
220 EYE PAIN 13 0.0002
221 IMMOBILE 1 0.0002
222 JOINT STIFFNESS 6 0.0002
223 SLEEP DISORDER 16 0.0002
224 BLOOD CREATINE INCREASED 1 0.0002
225 RHEUMATIC FEVER 1 0.0002
226 OPTIC NEURITIS 2 0.0002
227 EYE OPERATION 1 0.0002
228 COLORECTAL CANCER STAGE IV 1 0.0002
229 INTERCEPTED MEDICATION ERROR 1 0.0002
230 SKIN REACTION 3 0.0002
231 VAGINAL INFECTION 1 0.0002
232 SPUTUM DISCOLOURED 2 0.0002
233 FINGER DEFORMITY 1 0.0002
234 MULTIPLE DRUG OVERDOSE 1 0.0002
235 BRAIN INJURY 2 0.0002
236 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
237 EAR DISCOMFORT 2 0.0002
238 TEMPERATURE INTOLERANCE 2 0.0002
239 TRISMUS 1 0.0002
240 SKIN NECROSIS 1 0.0002
241 PERIORBITAL OEDEMA 1 0.0002
242 SWOLLEN TONGUE 6 0.0002
243 BALANCE DISORDER 16 0.0002
244 ERYTHEMA OF EYELID 1 0.0002
245 SKIN LESION 5 0.0002
246 ILL-DEFINED DISORDER 11 0.0002
247 GASTRIC ULCER HAEMORRHAGE 1 0.0002
248 DISCOMFORT 11 0.0002
249 VENTRICULAR FIBRILLATION 2 0.0002
250 PERIORBITAL SWELLING 1 0.0002
251 PAIN IN JAW 5 0.0002
252 HYPERTONIA 1 0.0002
253 RHEUMATOID FACTOR POSITIVE 1 0.0002
254 RALES 1 0.0002
255 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
256 MYOCLONUS 2 0.0002
257 WITHDRAWAL SYNDROME 7 0.0002
258 FOETAL GROWTH RESTRICTION 1 0.0002
259 PRESCRIBED OVERDOSE 3 0.0002
260 INCOHERENT 1 0.0002
261 TENDON DISORDER 1 0.0002
262 DEAFNESS 4 0.0002
263 SOMNAMBULISM 1 0.0002
264 TOOTH INFECTION 2 0.0002
265 LIP SWELLING 5 0.0001
266 FUNGAL INFECTION 5 0.0001
267 POST-TRAUMATIC STRESS DISORDER 1 0.0001
268 DISTURBANCE IN ATTENTION 8 0.0001
269 BODY TEMPERATURE INCREASED 3 0.0001
270 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
271 TACHYCARDIA 13 0.0001
272 HOT FLUSH 11 0.0001
273 SEASONAL ALLERGY 2 0.0001
274 DRUG INTERACTION 22 0.0001
275 DERMATITIS BULLOUS 1 0.0001
276 HYPOKINESIA 2 0.0001
277 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
278 HYPOPHOSPHATAEMIA 1 0.0001
279 ARTHROPOD BITE 1 0.0001
280 DYSARTHRIA 5 0.0001
281 HYPOAESTHESIA ORAL 2 0.0001
282 TROPONIN INCREASED 1 0.0001
283 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
284 RENAL FAILURE CHRONIC 1 0.0001
285 SOMNOLENCE 26 0.0001
286 VISUAL IMPAIRMENT 16 0.0001
287 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
288 THERAPY PARTIAL RESPONDER 2 0.0001
289 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
290 PRODUCT PRESCRIBING ERROR 3 0.0001
291 SCIATICA 2 0.0001
292 SENSORY LOSS 1 0.0001
293 MYASTHENIA GRAVIS 1 0.0001
294 MUSCLE TIGHTNESS 2 0.0001
295 POLYURIA 1 0.0001
296 ABNORMAL FAECES 1 0.0001
297 ESCHERICHIA INFECTION 1 0.0001
298 MUSCLE INJURY 1 0.0001
299 SENSATION OF FOREIGN BODY 1 0.0001
300 INFLAMMATION 6 0.0001
301 DEVICE DEFECTIVE 2 0.0001
302 ECZEMA 6 0.0001
303 BLOOD CALCIUM INCREASED 1 0.0001
304 SPINAL OSTEOARTHRITIS 1 0.0001
305 THROAT IRRITATION 5 0.0001
306 LUPUS-LIKE SYNDROME 1 0.0001
307 RETINAL DETACHMENT 1 0.0001
308 GRAND MAL CONVULSION 1 0.0001
309 APPENDICITIS 1 0.0001
310 ABORTION INDUCED 1 0.0001
311 ANAEMIA 20 0.0001
312 RECALLED PRODUCT ADMINISTERED 1 0.0001
313 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
314 EAR PAIN 2 0.0001
315 AUTOIMMUNE DISORDER 1 0.0001
316 INABILITY TO AFFORD MEDICATION 1 0.0001
317 ABORTION SPONTANEOUS 4 0.0001
318 INTENTIONAL SELF-INJURY 2 0.0001
319 SLUGGISHNESS 1 0.0001
320 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
321 DEPRESSION 22 0.0001
322 POOR VENOUS ACCESS 1 0.0001
323 WEIGHT FLUCTUATION 1 0.0001
324 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
325 JOINT DISLOCATION 1 0.0001
326 OSTEOARTHRITIS 4 0.0001
327 DRUG INTOLERANCE 9 0.0001
328 LIVER FUNCTION TEST INCREASED 2 0.0001
329 BIPOLAR DISORDER 1 0.0001
330 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
331 PARAESTHESIA 14 0.0001
332 GAIT DISTURBANCE 17 0.0001
333 MITRAL VALVE INCOMPETENCE 1 0.0001
334 IMPAIRED DRIVING ABILITY 1 0.0001
335 EYELID OEDEMA 1 0.0001
336 BLOOD CHOLESTEROL INCREASED 4 0.0001
337 FALL 28 0.0001
338 CEREBRAL HAEMORRHAGE 3 0.0001
339 HYPERLIPIDAEMIA 1 0.0001
340 THYROID CANCER 1 0.0001
341 FIBROMYALGIA 2 0.0001
342 SPINAL OPERATION 1 0.0001
343 PEMPHIGUS 1 0.0001
344 SKIN ULCER 2 0.0001
345 SWELLING FACE 5 0.0001
346 RESPIRATORY TRACT INFECTION 2 0.0001
347 ARTHRITIS 6 0.0001
348 WEIGHT INCREASED 17 0.0001
349 INFUSION RELATED REACTION 5 0.0001
350 INSOMNIA 20 0.0001
351 THROAT TIGHTNESS 2 0.0001
352 LIMB INJURY 2 0.0001
353 IMPAIRED GASTRIC EMPTYING 1 0.0001
354 BACK PAIN 17 0.0001
355 VISION BLURRED 10 0.0001
356 APHONIA 1 0.0001
357 BLOOD TEST ABNORMAL 1 0.0001
358 SINUS TACHYCARDIA 1 0.0001
359 BRONCHOSPASM 1 0.0001
360 CARDIOGENIC SHOCK 1 0.0001
361 MOBILITY DECREASED 5 0.0001
362 HYPERTHYROIDISM 1 0.0001
363 FLUSHING 7 0.0001
364 NEEDLE ISSUE 2 0.0001
365 INTENTIONAL PRODUCT MISUSE 6 0.0001
366 CONFUSIONAL STATE 11 0.0001
367 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
368 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
369 BONE LOSS 1 0.0001
370 TREMOR 11 0.0001
371 PLEURAL EFFUSION 4 0.0001
372 HEADACHE 41 0.0001
373 DEVICE RELATED INFECTION 1 0.0001
374 ULCER 1 0.0001
375 PREMATURE DELIVERY 1 0.0001
376 INFLUENZA 7 0.0001
377 CONDITION AGGRAVATED 19 0.0001
378 OSTEONECROSIS 2 0.0001
379 DRY EYE 3 0.0001
380 PERICARDITIS 1 0.0001
381 SINUSITIS 6 0.0001
382 PRODUCT USE ISSUE 11 0.0001
383 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
384 ORTHOSTATIC HYPOTENSION 1 0.0001
385 PAIN 35 0.0001
386 DEVICE ISSUE 5 0.0001
387 GOUT 1 0.0001
388 SYNOVITIS 1 0.0001
389 END STAGE RENAL DISEASE 1 0.0001
390 MALAISE 24 0.0001
391 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
392 MUSCLE SPASMS 10 0.0001
393 DIZZINESS 27 0.0001
394 ARTHROPATHY 3 0.0001
395 BACTERIAL INFECTION 1 0.0001
396 ASTHMA 6 0.0001
397 RHEUMATOID ARTHRITIS 6 0.0001
398 GASTRIC ULCER 1 0.0001
399 INCORRECT DOSE ADMINISTERED 12 0.0001
400 SLEEP APNOEA SYNDROME 1 0.0001
401 BLOOD PRESSURE INCREASED 8 0.0001
402 PULMONARY FIBROSIS 1 0.0001
403 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
404 LOWER LIMB FRACTURE 1 0.0001
405 FATIGUE 40 0.0001
406 DISEASE PROGRESSION 6 0.0001
407 WHEEZING 3 0.0001
408 DISORIENTATION 2 0.0001
409 PRESCRIBED UNDERDOSE 1 0.0001
410 IRRITABILITY 3 0.0000
411 PRODUCT ADMINISTRATION ERROR 1 0.0000
412 FEEDING DISORDER 1 0.0000
413 PSORIATIC ARTHROPATHY 2 0.0000
414 ILLNESS 5 0.0000
415 EXPOSURE DURING PREGNANCY 3 0.0000
416 ASTHENIA 18 0.0000
417 INTENTIONAL DRUG MISUSE 1 0.0000
418 ROAD TRAFFIC ACCIDENT 2 0.0000
419 HALLUCINATION, VISUAL 1 0.0000
420 INTENTIONAL OVERDOSE 3 0.0000
421 OVERDOSE 10 0.0000
422 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
423 TRANSAMINASES INCREASED 1 0.0000
424 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
425 PRODUCT QUALITY ISSUE 6 0.0000
426 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
427 TINNITUS 2 0.0000
428 PALPITATIONS 5 0.0000
429 ANXIETY 12 0.0000
430 PRODUCTIVE COUGH 2 0.0000
431 JOINT SWELLING 5 0.0000
432 MENTAL IMPAIRMENT 1 0.0000
433 NEURALGIA 1 0.0000
434 ARTHRALGIA 17 0.0000
435 LUNG DISORDER 2 0.0000
436 LIVER INJURY 1 0.0000
437 BRONCHITIS 3 0.0000
438 EXTRAPYRAMIDAL DISORDER 1 0.0000
439 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7 0.0000
440 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
441 VOMITING 18 0.0000
442 NERVOUSNESS 2 0.0000
443 INJECTION SITE BRUISING 3 0.0000
444 PALLOR 1 0.0000
445 RESPIRATORY DISTRESS 1 0.0000
446 DRUG ABUSE 3 0.0000
447 FEELING COLD 1 0.0000
448 WOUND 1 0.0000
449 HYPONATRAEMIA 2 0.0000
450 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
451 INFECTION 5 0.0000
452 DYSSTASIA 1 0.0000
453 COVID-19 6 0.0000
454 BONE PAIN 2 0.0000
455 NASAL CONGESTION 2 0.0000
456 ASCITES 1 0.0000
457 PRODUCT DOSE OMISSION ISSUE 10 0.0000
458 ACUTE MYOCARDIAL INFARCTION 1 0.0000
459 PSYCHOTIC DISORDER 1 0.0000
460 HYPOAESTHESIA 5 0.0000
461 PREMATURE BABY 1 0.0000
462 OEDEMA PERIPHERAL 4 0.0000
463 NASOPHARYNGITIS 6 0.0000
464 DRUG-INDUCED LIVER INJURY 1 0.0000
465 HEAD INJURY 1 0.0000
466 PRURITUS 12 0.0000
467 HIP FRACTURE 1 0.0000
468 RHINORRHOEA 2 0.0000
469 HEART RATE INCREASED 3 0.0000
470 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
471 ABDOMINAL PAIN 7 0.0000
472 EXPIRED PRODUCT ADMINISTERED 1 0.0000
473 TYPE 2 DIABETES MELLITUS 1 0.0000
474 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
475 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
476 ABDOMINAL DISTENSION 3 0.0000
477 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
478 DRUG EFFECT INCOMPLETE 1 0.0000
479 C-REACTIVE PROTEIN INCREASED 1 0.0000
480 PANIC ATTACK 1 0.0000
481 EYE SWELLING 1 0.0000
482 INTESTINAL OBSTRUCTION 1 0.0000
483 MUSCULAR WEAKNESS 3 0.0000
484 COLITIS 1 0.0000
485 INJECTION SITE SWELLING 2 0.0000
486 WEIGHT DECREASED 7 0.0000
487 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
488 EXTRA DOSE ADMINISTERED 1 0.0000
489 OSTEOPOROSIS 1 0.0000
490 CARDIO-RESPIRATORY ARREST 1 0.0000
491 PYREXIA 8 0.0000
492 COLITIS ULCERATIVE 1 0.0000
493 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
494 MEMORY IMPAIRMENT 3 0.0000
495 SKIN IRRITATION 1 0.0000
496 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
497 SWELLING 2 0.0000
498 ARRHYTHMIA 1 0.0000
499 MULTIPLE SCLEROSIS 1 0.0000
500 CELLULITIS 1 0.0000
501 CHEST DISCOMFORT 2 0.0000
502 PERIPHERAL SWELLING 3 0.0000
503 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
504 DERMATITIS ATOPIC 1 0.0000
505 DEPRESSED MOOD 1 0.0000
506 PNEUMONIA 6 0.0000
507 OEDEMA 1 0.0000
508 CONSTIPATION 4 0.0000
509 DRUG DOSE OMISSION 3 0.0000
510 ANAPHYLACTIC REACTION 1 0.0000
511 URTICARIA 3 0.0000
512 COUGH 5 0.0000
513 URINARY TRACT INFECTION 3 0.0000
514 EYE IRRITATION 1 0.0000
515 CHILLS 2 0.0000
516 LOSS OF CONSCIOUSNESS 2 0.0000
517 DEEP VEIN THROMBOSIS 1 0.0000
518 ALOPECIA 3 0.0000
519 BLOOD PRESSURE DECREASED 1 0.0000
520 HEPATIC ENZYME INCREASED 1 0.0000
521 DYSPNOEA 8 0.0000
522 THERAPY INTERRUPTED 1 0.0000
523 RASH 6 0.0000
524 DYSGEUSIA 1 0.0000
525 UNEVALUABLE EVENT 1 0.0000
526 DIABETES MELLITUS 1 0.0000
527 INJECTION SITE PAIN 4 0.0000
528 INJECTION SITE HAEMORRHAGE 1 0.0000
529 FEELING ABNORMAL 3 0.0000
530 THROMBOSIS 1 0.0000
531 DRY MOUTH 1 0.0000
532 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
533 INFLUENZA LIKE ILLNESS 1 0.0000
534 COMPLETED SUICIDE 1 0.0000
535 ABDOMINAL DISCOMFORT 2 0.0000
536 TOXICITY TO VARIOUS AGENTS 2 0.0000
537 MYALGIA 2 0.0000
538 PRODUCT STORAGE ERROR 1 0.0000
539 GASTROINTESTINAL DISORDER 1 0.0000
540 SUICIDAL IDEATION 1 0.0000
541 ADVERSE EVENT 1 0.0000
542 DIARRHOEA 7 0.0000
543 HYPERSENSITIVITY 2 0.0000
544 CARDIAC DISORDER 1 0.0000
545 PULMONARY EMBOLISM 1 0.0000
546 NEUROPATHY PERIPHERAL 1 0.0000
547 PAIN IN EXTREMITY 3 0.0000
548 HAEMOGLOBIN DECREASED 1 0.0000
549 ERYTHEMA 2 0.0000
550 ABDOMINAL PAIN UPPER 2 0.0000
551 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
552 SEPSIS 1 0.0000
553 SEIZURE 1 0.0000
554 PSORIASIS 1 0.0000
555 DEHYDRATION 1 0.0000
556 DRY SKIN 1 0.0000
557 MYOCARDIAL INFARCTION 1 0.0000
558 HYPERTENSION 1 0.0000
559 DECREASED APPETITE 1 0.0000
560 DEATH 1 0.0000